0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Fukangning Tablets Market Research Report 2026
Published Date: 2026-01-28
|
Report Code: QYRE-Auto-0M19015
Home | Market Reports
Global Fukangning Tablets Market Research Report 2024
BUY CHAPTERS

Global Fukangning Tablets Market Research Report 2026

Code: QYRE-Auto-0M19015
Report
2026-01-28
Pages:138
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Fukangning Tablets Market Size

The global Fukangning Tablets market was valued at US$ 51.65 million in 2025 and is anticipated to reach US$ 74.06 million by 2032, at a CAGR of 5.4% from 2026 to 2032.

Fukangning Tablets Market

Fukangning Tablets Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Fukangning Tablets competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Fukangning Tablets is a Chinese patent medicine, composed of Chinese Angelica, Leonurus japonicus, Rehmannia glutinosa, Cyperus rotundus, White Peony Root, Corydalis yanhusuo, Artemisia argyi, etc. It has the effects of regulating menstruation, nourishing blood, regulating qi and relieving pain, and can be used to treat irregular menstruation, dysmenorrhea and postpartum abdominal pain caused by stagnation of qi and blood.
The North American market for Fukangning Tablets is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Fukangning Tablets is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Fukangning Tablets include Yantai Bohai Pharmaceutical Group Co., Ltd., Guangzhou Xiangxue Pharmaceutical Co., Ltd., Lanzhou Foci Pharmaceutical Co., Ltd., Guangxi Shuangyi Pharmaceutical Co., Ltd., Guangxi Bangqi Pharmaceutical Group Co., Ltd., Guangxi Fanglue Pharmaceutical Group Co., Ltd., Tonghua Baixin Pharmaceutical Co., Ltd., Yili Pharmaceutical (Nanning) Co., Ltd., Jilin Jurentang Pharmaceutical Co., Ltd., Jinhua Kangshou Pharmaceutical Co., Ltd., etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Fukangning Tablets market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Fukangning Tablets. The Fukangning Tablets market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Fukangning Tablets market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Fukangning Tablets manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Fukangning Tablets Market Report

Report Metric Details
Report Name Fukangning Tablets Market
Accounted market size in 2025 US$ 51.65 million
Forecasted market size in 2032 US$ 74.06 million
CAGR 5.4%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Film-coated Tablets
  • Sugar-coated Tablets
by Application
  • Hospital
  • Clinic
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Yantai Bohai Pharmaceutical Group Co., Ltd., Guangzhou Xiangxue Pharmaceutical Co., Ltd., Lanzhou Foci Pharmaceutical Co., Ltd., Guangxi Shuangyi Pharmaceutical Co., Ltd., Guangxi Bangqi Pharmaceutical Group Co., Ltd., Guangxi Fanglue Pharmaceutical Group Co., Ltd., Tonghua Baixin Pharmaceutical Co., Ltd., Yili Pharmaceutical (Nanning) Co., Ltd., Jilin Jurentang Pharmaceutical Co., Ltd., Jinhua Kangshou Pharmaceutical Co., Ltd., Jiangsu Yihai Pharmaceutical Co., Ltd., Shaanxi Kanghui Pharmaceutical Co., Ltd., Shaanxi Panlong Pharmaceutical Group Co., Ltd., Huaihua Zhenghao Pharmaceutical Co., Ltd., Liaoning Dongfangren Pharmaceutical Co., Ltd., Henan Zhongjing Pharmaceutical Co., Ltd., Sanmenxia Guangyu Biopharmaceutical Co., Ltd., Shaanxi Ziguang Chenji Pharmaceutical Co., Ltd., Lanzhou Weici Pharmaceutical Co., Ltd., Guangxi Weiwe Pharmaceutical Co., Ltd., Guangxi Jinsuozi Pharmaceutical Co., Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Fukangning Tablets manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Fukangning Tablets sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Fukangning Tablets Market growing?

Ans: The Fukangning Tablets Market witnessing a CAGR of 5.4% during the forecast period 2026-2032.

What is the Fukangning Tablets Market size in 2032?

Ans: The Fukangning Tablets Market size in 2032 will be US$ 74.06 million.

Who are the main players in the Fukangning Tablets Market report?

Ans: The main players in the Fukangning Tablets Market are Yantai Bohai Pharmaceutical Group Co., Ltd., Guangzhou Xiangxue Pharmaceutical Co., Ltd., Lanzhou Foci Pharmaceutical Co., Ltd., Guangxi Shuangyi Pharmaceutical Co., Ltd., Guangxi Bangqi Pharmaceutical Group Co., Ltd., Guangxi Fanglue Pharmaceutical Group Co., Ltd., Tonghua Baixin Pharmaceutical Co., Ltd., Yili Pharmaceutical (Nanning) Co., Ltd., Jilin Jurentang Pharmaceutical Co., Ltd., Jinhua Kangshou Pharmaceutical Co., Ltd., Jiangsu Yihai Pharmaceutical Co., Ltd., Shaanxi Kanghui Pharmaceutical Co., Ltd., Shaanxi Panlong Pharmaceutical Group Co., Ltd., Huaihua Zhenghao Pharmaceutical Co., Ltd., Liaoning Dongfangren Pharmaceutical Co., Ltd., Henan Zhongjing Pharmaceutical Co., Ltd., Sanmenxia Guangyu Biopharmaceutical Co., Ltd., Shaanxi Ziguang Chenji Pharmaceutical Co., Ltd., Lanzhou Weici Pharmaceutical Co., Ltd., Guangxi Weiwe Pharmaceutical Co., Ltd., Guangxi Jinsuozi Pharmaceutical Co., Ltd.

What are the Application segmentation covered in the Fukangning Tablets Market report?

Ans: The Applications covered in the Fukangning Tablets Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Fukangning Tablets Market report?

Ans: The Types covered in the Fukangning Tablets Market report are Film-coated Tablets, Sugar-coated Tablets

1 Fukangning Tablets Market Overview
1.1 Product Definition
1.2 Fukangning Tablets by Type
1.2.1 Global Fukangning Tablets Market Value by Type: 2025 vs 2032
1.2.2 Film-coated Tablets
1.2.3 Sugar-coated Tablets
1.3 Fukangning Tablets by Application
1.3.1 Global Fukangning Tablets Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Fukangning Tablets Market Size Estimates and Forecasts
1.4.1 Global Fukangning Tablets Revenue 2021–2032
1.4.2 Global Fukangning Tablets Sales 2021–2032
1.4.3 Global Fukangning Tablets Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Fukangning Tablets Market Competition by Manufacturers
2.1 Global Fukangning Tablets Sales Market Share by Manufacturers (2021–2026)
2.2 Global Fukangning Tablets Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Fukangning Tablets Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Fukangning Tablets, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Fukangning Tablets, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Fukangning Tablets, Product Types and Applications
2.7 Global Key Manufacturers of Fukangning Tablets, Date of Entry into the Industry
2.8 Global Fukangning Tablets Market Competitive Situation and Trends
2.8.1 Global Fukangning Tablets Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Fukangning Tablets Players Market Share by Revenue
2.8.3 Global Fukangning Tablets Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Fukangning Tablets Market Scenario by Region
3.1 Global Fukangning Tablets Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Fukangning Tablets Sales by Region: 2021–2032
3.2.1 Global Fukangning Tablets Sales by Region: 2021–2026
3.2.2 Global Fukangning Tablets Sales by Region: 2027–2032
3.3 Global Fukangning Tablets Revenue by Region: 2021–2032
3.3.1 Global Fukangning Tablets Revenue by Region: 2021–2026
3.3.2 Global Fukangning Tablets Revenue by Region: 2027–2032
3.4 North America Fukangning Tablets Market Facts & Figures by Country
3.4.1 North America Fukangning Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Fukangning Tablets Sales by Country (2021–2032)
3.4.3 North America Fukangning Tablets Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Fukangning Tablets Market Facts & Figures by Country
3.5.1 Europe Fukangning Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Fukangning Tablets Sales by Country (2021–2032)
3.5.3 Europe Fukangning Tablets Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Fukangning Tablets Market Facts & Figures by Region
3.6.1 Asia Pacific Fukangning Tablets Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Fukangning Tablets Sales by Region (2021–2032)
3.6.3 Asia Pacific Fukangning Tablets Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Fukangning Tablets Market Facts & Figures by Country
3.7.1 Latin America Fukangning Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Fukangning Tablets Sales by Country (2021–2032)
3.7.3 Latin America Fukangning Tablets Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Fukangning Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Fukangning Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Fukangning Tablets Sales by Country (2021–2032)
3.8.3 Middle East and Africa Fukangning Tablets Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Fukangning Tablets Sales by Type (2021–2032)
4.1.1 Global Fukangning Tablets Sales by Type (2021–2026)
4.1.2 Global Fukangning Tablets Sales by Type (2027–2032)
4.1.3 Global Fukangning Tablets Sales Market Share by Type (2021–2032)
4.2 Global Fukangning Tablets Revenue by Type (2021–2032)
4.2.1 Global Fukangning Tablets Revenue by Type (2021–2026)
4.2.2 Global Fukangning Tablets Revenue by Type (2027–2032)
4.2.3 Global Fukangning Tablets Revenue Market Share by Type (2021–2032)
4.3 Global Fukangning Tablets Price by Type (2021–2032)
5 Segment by Application
5.1 Global Fukangning Tablets Sales by Application (2021–2032)
5.1.1 Global Fukangning Tablets Sales by Application (2021–2026)
5.1.2 Global Fukangning Tablets Sales by Application (2027–2032)
5.1.3 Global Fukangning Tablets Sales Market Share by Application (2021–2032)
5.2 Global Fukangning Tablets Revenue by Application (2021–2032)
5.2.1 Global Fukangning Tablets Revenue by Application (2021–2026)
5.2.2 Global Fukangning Tablets Revenue by Application (2027–2032)
5.2.3 Global Fukangning Tablets Revenue Market Share by Application (2021–2032)
5.3 Global Fukangning Tablets Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Yantai Bohai Pharmaceutical Group Co., Ltd.
6.1.1 Yantai Bohai Pharmaceutical Group Co., Ltd. Company Information
6.1.2 Yantai Bohai Pharmaceutical Group Co., Ltd. Description and Business Overview
6.1.3 Yantai Bohai Pharmaceutical Group Co., Ltd. Fukangning Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Yantai Bohai Pharmaceutical Group Co., Ltd. Fukangning Tablets Product Portfolio
6.1.5 Yantai Bohai Pharmaceutical Group Co., Ltd. Recent Developments/Updates
6.2 Guangzhou Xiangxue Pharmaceutical Co., Ltd.
6.2.1 Guangzhou Xiangxue Pharmaceutical Co., Ltd. Company Information
6.2.2 Guangzhou Xiangxue Pharmaceutical Co., Ltd. Description and Business Overview
6.2.3 Guangzhou Xiangxue Pharmaceutical Co., Ltd. Fukangning Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Guangzhou Xiangxue Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio
6.2.5 Guangzhou Xiangxue Pharmaceutical Co., Ltd. Recent Developments/Updates
6.3 Lanzhou Foci Pharmaceutical Co., Ltd.
6.3.1 Lanzhou Foci Pharmaceutical Co., Ltd. Company Information
6.3.2 Lanzhou Foci Pharmaceutical Co., Ltd. Description and Business Overview
6.3.3 Lanzhou Foci Pharmaceutical Co., Ltd. Fukangning Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Lanzhou Foci Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio
6.3.5 Lanzhou Foci Pharmaceutical Co., Ltd. Recent Developments/Updates
6.4 Guangxi Shuangyi Pharmaceutical Co., Ltd.
6.4.1 Guangxi Shuangyi Pharmaceutical Co., Ltd. Company Information
6.4.2 Guangxi Shuangyi Pharmaceutical Co., Ltd. Description and Business Overview
6.4.3 Guangxi Shuangyi Pharmaceutical Co., Ltd. Fukangning Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Guangxi Shuangyi Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio
6.4.5 Guangxi Shuangyi Pharmaceutical Co., Ltd. Recent Developments/Updates
6.5 Guangxi Bangqi Pharmaceutical Group Co., Ltd.
6.5.1 Guangxi Bangqi Pharmaceutical Group Co., Ltd. Company Information
6.5.2 Guangxi Bangqi Pharmaceutical Group Co., Ltd. Description and Business Overview
6.5.3 Guangxi Bangqi Pharmaceutical Group Co., Ltd. Fukangning Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Guangxi Bangqi Pharmaceutical Group Co., Ltd. Fukangning Tablets Product Portfolio
6.5.5 Guangxi Bangqi Pharmaceutical Group Co., Ltd. Recent Developments/Updates
6.6 Guangxi Fanglue Pharmaceutical Group Co., Ltd.
6.6.1 Guangxi Fanglue Pharmaceutical Group Co., Ltd. Company Information
6.6.2 Guangxi Fanglue Pharmaceutical Group Co., Ltd. Description and Business Overview
6.6.3 Guangxi Fanglue Pharmaceutical Group Co., Ltd. Fukangning Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Guangxi Fanglue Pharmaceutical Group Co., Ltd. Fukangning Tablets Product Portfolio
6.6.5 Guangxi Fanglue Pharmaceutical Group Co., Ltd. Recent Developments/Updates
6.7 Tonghua Baixin Pharmaceutical Co., Ltd.
6.7.1 Tonghua Baixin Pharmaceutical Co., Ltd. Company Information
6.7.2 Tonghua Baixin Pharmaceutical Co., Ltd. Description and Business Overview
6.7.3 Tonghua Baixin Pharmaceutical Co., Ltd. Fukangning Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Tonghua Baixin Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio
6.7.5 Tonghua Baixin Pharmaceutical Co., Ltd. Recent Developments/Updates
6.8 Yili Pharmaceutical (Nanning) Co., Ltd.
6.8.1 Yili Pharmaceutical (Nanning) Co., Ltd. Company Information
6.8.2 Yili Pharmaceutical (Nanning) Co., Ltd. Description and Business Overview
6.8.3 Yili Pharmaceutical (Nanning) Co., Ltd. Fukangning Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Yili Pharmaceutical (Nanning) Co., Ltd. Fukangning Tablets Product Portfolio
6.8.5 Yili Pharmaceutical (Nanning) Co., Ltd. Recent Developments/Updates
6.9 Jilin Jurentang Pharmaceutical Co., Ltd.
6.9.1 Jilin Jurentang Pharmaceutical Co., Ltd. Company Information
6.9.2 Jilin Jurentang Pharmaceutical Co., Ltd. Description and Business Overview
6.9.3 Jilin Jurentang Pharmaceutical Co., Ltd. Fukangning Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Jilin Jurentang Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio
6.9.5 Jilin Jurentang Pharmaceutical Co., Ltd. Recent Developments/Updates
6.10 Jinhua Kangshou Pharmaceutical Co., Ltd.
6.10.1 Jinhua Kangshou Pharmaceutical Co., Ltd. Company Information
6.10.2 Jinhua Kangshou Pharmaceutical Co., Ltd. Description and Business Overview
6.10.3 Jinhua Kangshou Pharmaceutical Co., Ltd. Fukangning Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Jinhua Kangshou Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio
6.10.5 Jinhua Kangshou Pharmaceutical Co., Ltd. Recent Developments/Updates
6.11 Jiangsu Yihai Pharmaceutical Co., Ltd.
6.11.1 Jiangsu Yihai Pharmaceutical Co., Ltd. Company Information
6.11.2 Jiangsu Yihai Pharmaceutical Co., Ltd. Description and Business Overview
6.11.3 Jiangsu Yihai Pharmaceutical Co., Ltd. Fukangning Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Jiangsu Yihai Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio
6.11.5 Jiangsu Yihai Pharmaceutical Co., Ltd. Recent Developments/Updates
6.12 Shaanxi Kanghui Pharmaceutical Co., Ltd.
6.12.1 Shaanxi Kanghui Pharmaceutical Co., Ltd. Company Information
6.12.2 Shaanxi Kanghui Pharmaceutical Co., Ltd. Description and Business Overview
6.12.3 Shaanxi Kanghui Pharmaceutical Co., Ltd. Fukangning Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Shaanxi Kanghui Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio
6.12.5 Shaanxi Kanghui Pharmaceutical Co., Ltd. Recent Developments/Updates
6.13 Shaanxi Panlong Pharmaceutical Group Co., Ltd.
6.13.1 Shaanxi Panlong Pharmaceutical Group Co., Ltd. Company Information
6.13.2 Shaanxi Panlong Pharmaceutical Group Co., Ltd. Description and Business Overview
6.13.3 Shaanxi Panlong Pharmaceutical Group Co., Ltd. Fukangning Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Shaanxi Panlong Pharmaceutical Group Co., Ltd. Fukangning Tablets Product Portfolio
6.13.5 Shaanxi Panlong Pharmaceutical Group Co., Ltd. Recent Developments/Updates
6.14 Huaihua Zhenghao Pharmaceutical Co., Ltd.
6.14.1 Huaihua Zhenghao Pharmaceutical Co., Ltd. Company Information
6.14.2 Huaihua Zhenghao Pharmaceutical Co., Ltd. Description and Business Overview
6.14.3 Huaihua Zhenghao Pharmaceutical Co., Ltd. Fukangning Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Huaihua Zhenghao Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio
6.14.5 Huaihua Zhenghao Pharmaceutical Co., Ltd. Recent Developments/Updates
6.15 Liaoning Dongfangren Pharmaceutical Co., Ltd.
6.15.1 Liaoning Dongfangren Pharmaceutical Co., Ltd. Company Information
6.15.2 Liaoning Dongfangren Pharmaceutical Co., Ltd. Description and Business Overview
6.15.3 Liaoning Dongfangren Pharmaceutical Co., Ltd. Fukangning Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Liaoning Dongfangren Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio
6.15.5 Liaoning Dongfangren Pharmaceutical Co., Ltd. Recent Developments/Updates
6.16 Henan Zhongjing Pharmaceutical Co., Ltd.
6.16.1 Henan Zhongjing Pharmaceutical Co., Ltd. Company Information
6.16.2 Henan Zhongjing Pharmaceutical Co., Ltd. Description and Business Overview
6.16.3 Henan Zhongjing Pharmaceutical Co., Ltd. Fukangning Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Henan Zhongjing Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio
6.16.5 Henan Zhongjing Pharmaceutical Co., Ltd. Recent Developments/Updates
6.17 Sanmenxia Guangyu Biopharmaceutical Co., Ltd.
6.17.1 Sanmenxia Guangyu Biopharmaceutical Co., Ltd. Company Information
6.17.2 Sanmenxia Guangyu Biopharmaceutical Co., Ltd. Description and Business Overview
6.17.3 Sanmenxia Guangyu Biopharmaceutical Co., Ltd. Fukangning Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Sanmenxia Guangyu Biopharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio
6.17.5 Sanmenxia Guangyu Biopharmaceutical Co., Ltd. Recent Developments/Updates
6.18 Shaanxi Ziguang Chenji Pharmaceutical Co., Ltd.
6.18.1 Shaanxi Ziguang Chenji Pharmaceutical Co., Ltd. Company Information
6.18.2 Shaanxi Ziguang Chenji Pharmaceutical Co., Ltd. Description and Business Overview
6.18.3 Shaanxi Ziguang Chenji Pharmaceutical Co., Ltd. Fukangning Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Shaanxi Ziguang Chenji Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio
6.18.5 Shaanxi Ziguang Chenji Pharmaceutical Co., Ltd. Recent Developments/Updates
6.19 Lanzhou Weici Pharmaceutical Co., Ltd.
6.19.1 Lanzhou Weici Pharmaceutical Co., Ltd. Company Information
6.19.2 Lanzhou Weici Pharmaceutical Co., Ltd. Description and Business Overview
6.19.3 Lanzhou Weici Pharmaceutical Co., Ltd. Fukangning Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Lanzhou Weici Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio
6.19.5 Lanzhou Weici Pharmaceutical Co., Ltd. Recent Developments/Updates
6.20 Guangxi Weiwe Pharmaceutical Co., Ltd.
6.20.1 Guangxi Weiwe Pharmaceutical Co., Ltd. Company Information
6.20.2 Guangxi Weiwe Pharmaceutical Co., Ltd. Description and Business Overview
6.20.3 Guangxi Weiwe Pharmaceutical Co., Ltd. Fukangning Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.20.4 Guangxi Weiwe Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio
6.20.5 Guangxi Weiwe Pharmaceutical Co., Ltd. Recent Developments/Updates
6.21 Guangxi Jinsuozi Pharmaceutical Co., Ltd.
6.21.1 Guangxi Jinsuozi Pharmaceutical Co., Ltd. Company Information
6.21.2 Guangxi Jinsuozi Pharmaceutical Co., Ltd. Description and Business Overview
6.21.3 Guangxi Jinsuozi Pharmaceutical Co., Ltd. Fukangning Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.21.4 Guangxi Jinsuozi Pharmaceutical Co., Ltd. Fukangning Tablets Product Portfolio
6.21.5 Guangxi Jinsuozi Pharmaceutical Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Fukangning Tablets Industry Chain Analysis
7.2 Fukangning Tablets Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Fukangning Tablets Production Mode & Process Analysis
7.4 Fukangning Tablets Sales and Marketing
7.4.1 Fukangning Tablets Sales Channels
7.4.2 Fukangning Tablets Distributors
7.5 Fukangning Tablets Customer Analysis
8 Fukangning Tablets Market Dynamics
8.1 Fukangning Tablets Industry Trends
8.2 Fukangning Tablets Market Drivers
8.3 Fukangning Tablets Market Challenges
8.4 Fukangning Tablets Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Fukangning Tablets Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Fukangning Tablets Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Fukangning Tablets Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Fukangning Tablets Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Fukangning Tablets Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Fukangning Tablets Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Fukangning Tablets Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Fukangning Tablets Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Fukangning Tablets, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Fukangning Tablets, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Fukangning Tablets, Product Types and Applications
 Table 12. Global Key Manufacturers of Fukangning Tablets, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Fukangning Tablets Companies by Tier (Tier 1, Tier 2, Tier 3), based on Fukangning Tablets Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Fukangning Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Fukangning Tablets Sales by Region (K Units), 2021–2026
 Table 18. Global Fukangning Tablets Sales Market Share by Region (2021–2026)
 Table 19. Global Fukangning Tablets Sales by Region (K Units), 2027–2032
 Table 20. Global Fukangning Tablets Sales Market Share by Region (2027–2032)
 Table 21. Global Fukangning Tablets Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Fukangning Tablets Revenue Market Share by Region (2021–2026)
 Table 23. Global Fukangning Tablets Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Fukangning Tablets Revenue Market Share by Region (2027–2032)
 Table 25. North America Fukangning Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Fukangning Tablets Sales by Country (K Units), 2021–2026
 Table 27. North America Fukangning Tablets Sales by Country (K Units), 2027–2032
 Table 28. North America Fukangning Tablets Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Fukangning Tablets Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Fukangning Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Fukangning Tablets Sales by Country (K Units), 2021–2026
 Table 32. Europe Fukangning Tablets Sales by Country (K Units), 2027–2032
 Table 33. Europe Fukangning Tablets Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Fukangning Tablets Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Fukangning Tablets Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Fukangning Tablets Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Fukangning Tablets Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Fukangning Tablets Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Fukangning Tablets Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Fukangning Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Fukangning Tablets Sales by Country (K Units), 2021–2026
 Table 42. Latin America Fukangning Tablets Sales by Country (K Units), 2027–2032
 Table 43. Latin America Fukangning Tablets Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Fukangning Tablets Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Fukangning Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Fukangning Tablets Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Fukangning Tablets Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Fukangning Tablets Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Fukangning Tablets Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Fukangning Tablets Sales (K Units) by Type (2021–2026)
 Table 51. Global Fukangning Tablets Sales (K Units) by Type (2027–2032)
 Table 52. Global Fukangning Tablets Sales Market Share by Type (2021–2026)
 Table 53. Global Fukangning Tablets Sales Market Share by Type (2027–2032)
 Table 54. Global Fukangning Tablets Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Fukangning Tablets Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Fukangning Tablets Revenue Market Share by Type (2021–2026)
 Table 57. Global Fukangning Tablets Revenue Market Share by Type (2027–2032)
 Table 58. Global Fukangning Tablets Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Fukangning Tablets Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Fukangning Tablets Sales (K Units) by Application (2021–2026)
 Table 61. Global Fukangning Tablets Sales (K Units) by Application (2027–2032)
 Table 62. Global Fukangning Tablets Sales Market Share by Application (2021–2026)
 Table 63. Global Fukangning Tablets Sales Market Share by Application (2027–2032)
 Table 64. Global Fukangning Tablets Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Fukangning Tablets Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Fukangning Tablets Revenue Market Share by Application (2021–2026)
 Table 67. Global Fukangning Tablets Revenue Market Share by Application (2027–2032)
 Table 68. Global Fukangning Tablets Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Fukangning Tablets Price (US$/Unit) by Application (2027–2032)
 Table 70. Yantai Bohai Pharmaceutical Group Co., Ltd. Company Information
 Table 71. Yantai Bohai Pharmaceutical Group Co., Ltd. Description and Business Overview
 Table 72. Yantai Bohai Pharmaceutical Group Co., Ltd. Fukangning Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Yantai Bohai Pharmaceutical Group Co., Ltd. Fukangning Tablets Product
 Table 74. Yantai Bohai Pharmaceutical Group Co., Ltd. Recent Developments/Updates
 Table 75. Guangzhou Xiangxue Pharmaceutical Co., Ltd. Company Information
 Table 76. Guangzhou Xiangxue Pharmaceutical Co., Ltd. Description and Business Overview
 Table 77. Guangzhou Xiangxue Pharmaceutical Co., Ltd. Fukangning Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Guangzhou Xiangxue Pharmaceutical Co., Ltd. Fukangning Tablets Product
 Table 79. Guangzhou Xiangxue Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 80. Lanzhou Foci Pharmaceutical Co., Ltd. Company Information
 Table 81. Lanzhou Foci Pharmaceutical Co., Ltd. Description and Business Overview
 Table 82. Lanzhou Foci Pharmaceutical Co., Ltd. Fukangning Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Lanzhou Foci Pharmaceutical Co., Ltd. Fukangning Tablets Product
 Table 84. Lanzhou Foci Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 85. Guangxi Shuangyi Pharmaceutical Co., Ltd. Company Information
 Table 86. Guangxi Shuangyi Pharmaceutical Co., Ltd. Description and Business Overview
 Table 87. Guangxi Shuangyi Pharmaceutical Co., Ltd. Fukangning Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Guangxi Shuangyi Pharmaceutical Co., Ltd. Fukangning Tablets Product
 Table 89. Guangxi Shuangyi Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 90. Guangxi Bangqi Pharmaceutical Group Co., Ltd. Company Information
 Table 91. Guangxi Bangqi Pharmaceutical Group Co., Ltd. Description and Business Overview
 Table 92. Guangxi Bangqi Pharmaceutical Group Co., Ltd. Fukangning Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Guangxi Bangqi Pharmaceutical Group Co., Ltd. Fukangning Tablets Product
 Table 94. Guangxi Bangqi Pharmaceutical Group Co., Ltd. Recent Developments/Updates
 Table 95. Guangxi Fanglue Pharmaceutical Group Co., Ltd. Company Information
 Table 96. Guangxi Fanglue Pharmaceutical Group Co., Ltd. Description and Business Overview
 Table 97. Guangxi Fanglue Pharmaceutical Group Co., Ltd. Fukangning Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Guangxi Fanglue Pharmaceutical Group Co., Ltd. Fukangning Tablets Product
 Table 99. Guangxi Fanglue Pharmaceutical Group Co., Ltd. Recent Developments/Updates
 Table 100. Tonghua Baixin Pharmaceutical Co., Ltd. Company Information
 Table 101. Tonghua Baixin Pharmaceutical Co., Ltd. Description and Business Overview
 Table 102. Tonghua Baixin Pharmaceutical Co., Ltd. Fukangning Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. Tonghua Baixin Pharmaceutical Co., Ltd. Fukangning Tablets Product
 Table 104. Tonghua Baixin Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 105. Yili Pharmaceutical (Nanning) Co., Ltd. Company Information
 Table 106. Yili Pharmaceutical (Nanning) Co., Ltd. Description and Business Overview
 Table 107. Yili Pharmaceutical (Nanning) Co., Ltd. Fukangning Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Yili Pharmaceutical (Nanning) Co., Ltd. Fukangning Tablets Product
 Table 109. Yili Pharmaceutical (Nanning) Co., Ltd. Recent Developments/Updates
 Table 110. Jilin Jurentang Pharmaceutical Co., Ltd. Company Information
 Table 111. Jilin Jurentang Pharmaceutical Co., Ltd. Description and Business Overview
 Table 112. Jilin Jurentang Pharmaceutical Co., Ltd. Fukangning Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. Jilin Jurentang Pharmaceutical Co., Ltd. Fukangning Tablets Product
 Table 114. Jilin Jurentang Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 115. Jinhua Kangshou Pharmaceutical Co., Ltd. Company Information
 Table 116. Jinhua Kangshou Pharmaceutical Co., Ltd. Description and Business Overview
 Table 117. Jinhua Kangshou Pharmaceutical Co., Ltd. Fukangning Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. Jinhua Kangshou Pharmaceutical Co., Ltd. Fukangning Tablets Product
 Table 119. Jinhua Kangshou Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 120. Jiangsu Yihai Pharmaceutical Co., Ltd. Company Information
 Table 121. Jiangsu Yihai Pharmaceutical Co., Ltd. Description and Business Overview
 Table 122. Jiangsu Yihai Pharmaceutical Co., Ltd. Fukangning Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 123. Jiangsu Yihai Pharmaceutical Co., Ltd. Fukangning Tablets Product
 Table 124. Jiangsu Yihai Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 125. Shaanxi Kanghui Pharmaceutical Co., Ltd. Company Information
 Table 126. Shaanxi Kanghui Pharmaceutical Co., Ltd. Description and Business Overview
 Table 127. Shaanxi Kanghui Pharmaceutical Co., Ltd. Fukangning Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 128. Shaanxi Kanghui Pharmaceutical Co., Ltd. Fukangning Tablets Product
 Table 129. Shaanxi Kanghui Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 130. Shaanxi Panlong Pharmaceutical Group Co., Ltd. Company Information
 Table 131. Shaanxi Panlong Pharmaceutical Group Co., Ltd. Description and Business Overview
 Table 132. Shaanxi Panlong Pharmaceutical Group Co., Ltd. Fukangning Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 133. Shaanxi Panlong Pharmaceutical Group Co., Ltd. Fukangning Tablets Product
 Table 134. Shaanxi Panlong Pharmaceutical Group Co., Ltd. Recent Developments/Updates
 Table 135. Huaihua Zhenghao Pharmaceutical Co., Ltd. Company Information
 Table 136. Huaihua Zhenghao Pharmaceutical Co., Ltd. Description and Business Overview
 Table 137. Huaihua Zhenghao Pharmaceutical Co., Ltd. Fukangning Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 138. Huaihua Zhenghao Pharmaceutical Co., Ltd. Fukangning Tablets Product
 Table 139. Huaihua Zhenghao Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 140. Liaoning Dongfangren Pharmaceutical Co., Ltd. Company Information
 Table 141. Liaoning Dongfangren Pharmaceutical Co., Ltd. Description and Business Overview
 Table 142. Liaoning Dongfangren Pharmaceutical Co., Ltd. Fukangning Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 143. Liaoning Dongfangren Pharmaceutical Co., Ltd. Fukangning Tablets Product
 Table 144. Liaoning Dongfangren Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 145. Henan Zhongjing Pharmaceutical Co., Ltd. Company Information
 Table 146. Henan Zhongjing Pharmaceutical Co., Ltd. Description and Business Overview
 Table 147. Henan Zhongjing Pharmaceutical Co., Ltd. Fukangning Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 148. Henan Zhongjing Pharmaceutical Co., Ltd. Fukangning Tablets Product
 Table 149. Henan Zhongjing Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 150. Sanmenxia Guangyu Biopharmaceutical Co., Ltd. Company Information
 Table 151. Sanmenxia Guangyu Biopharmaceutical Co., Ltd. Description and Business Overview
 Table 152. Sanmenxia Guangyu Biopharmaceutical Co., Ltd. Fukangning Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 153. Sanmenxia Guangyu Biopharmaceutical Co., Ltd. Fukangning Tablets Product
 Table 154. Sanmenxia Guangyu Biopharmaceutical Co., Ltd. Recent Developments/Updates
 Table 155. Shaanxi Ziguang Chenji Pharmaceutical Co., Ltd. Company Information
 Table 156. Shaanxi Ziguang Chenji Pharmaceutical Co., Ltd. Description and Business Overview
 Table 157. Shaanxi Ziguang Chenji Pharmaceutical Co., Ltd. Fukangning Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 158. Shaanxi Ziguang Chenji Pharmaceutical Co., Ltd. Fukangning Tablets Product
 Table 159. Shaanxi Ziguang Chenji Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 160. Lanzhou Weici Pharmaceutical Co., Ltd. Company Information
 Table 161. Lanzhou Weici Pharmaceutical Co., Ltd. Description and Business Overview
 Table 162. Lanzhou Weici Pharmaceutical Co., Ltd. Fukangning Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 163. Lanzhou Weici Pharmaceutical Co., Ltd. Fukangning Tablets Product
 Table 164. Lanzhou Weici Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 165. Guangxi Weiwe Pharmaceutical Co., Ltd. Company Information
 Table 166. Guangxi Weiwe Pharmaceutical Co., Ltd. Description and Business Overview
 Table 167. Guangxi Weiwe Pharmaceutical Co., Ltd. Fukangning Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 168. Guangxi Weiwe Pharmaceutical Co., Ltd. Fukangning Tablets Product
 Table 169. Guangxi Weiwe Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 170. Guangxi Jinsuozi Pharmaceutical Co., Ltd. Company Information
 Table 171. Guangxi Jinsuozi Pharmaceutical Co., Ltd. Description and Business Overview
 Table 172. Guangxi Jinsuozi Pharmaceutical Co., Ltd. Fukangning Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 173. Guangxi Jinsuozi Pharmaceutical Co., Ltd. Fukangning Tablets Product
 Table 174. Guangxi Jinsuozi Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 175. Key Raw Materials Lists
 Table 176. Raw Materials Key Suppliers Lists
 Table 177. Fukangning Tablets Distributors List
 Table 178. Fukangning Tablets Customers List
 Table 179. Fukangning Tablets Market Trends
 Table 180. Fukangning Tablets Market Drivers
 Table 181. Fukangning Tablets Market Challenges
 Table 182. Fukangning Tablets Market Restraints
 Table 183. Research Programs/Design for This Report
 Table 184. Key Data Information from Secondary Sources
 Table 185. Key Data Information from Primary Sources
 Table 186. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Fukangning Tablets
 Figure 2. Global Fukangning Tablets Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Fukangning Tablets Market Share by Type: 2025 & 2032
 Figure 4. Film-coated Tablets Product Picture
 Figure 5. Sugar-coated Tablets Product Picture
 Figure 6. Global Fukangning Tablets Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Fukangning Tablets Market Share by Application: 2025 & 2032
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Other
 Figure 11. Global Fukangning Tablets Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global Fukangning Tablets Market Size (US$ Million), 2021–2032
 Figure 13. Global Fukangning Tablets Sales (K Units), 2021–2032
 Figure 14. Global Fukangning Tablets Average Price (US$/Unit), 2021–2032
 Figure 15. Fukangning Tablets Report Years Considered
 Figure 16. Fukangning Tablets Sales Share by Manufacturers in 2025
 Figure 17. Global Fukangning Tablets Revenue Share by Manufacturers in 2025
 Figure 18. Top 5 and Top 10 Global Fukangning Tablets Players: Market Share by Revenue in Fukangning Tablets in 2025
 Figure 19. Fukangning Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 20. Global Fukangning Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 21. North America Fukangning Tablets Sales Market Share by Country (2021–2032)
 Figure 22. North America Fukangning Tablets Revenue Market Share by Country (2021–2032)
 Figure 23. United States Fukangning Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Canada Fukangning Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Europe Fukangning Tablets Sales Market Share by Country (2021–2032)
 Figure 26. Europe Fukangning Tablets Revenue Market Share by Country (2021–2032)
 Figure 27. Germany Fukangning Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. France Fukangning Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. U.K. Fukangning Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Italy Fukangning Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Russia Fukangning Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Asia Pacific Fukangning Tablets Sales Market Share by Region (2021–2032)
 Figure 33. Asia Pacific Fukangning Tablets Revenue Market Share by Region (2021–2032)
 Figure 34. China Fukangning Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Japan Fukangning Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. South Korea Fukangning Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. India Fukangning Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Australia Fukangning Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. China Taiwan Fukangning Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Southeast Asia Fukangning Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Latin America Fukangning Tablets Sales Market Share by Country (2021–2032)
 Figure 42. Latin America Fukangning Tablets Revenue Market Share by Country (2021–2032)
 Figure 43. Mexico Fukangning Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Brazil Fukangning Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Argentina Fukangning Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Colombia Fukangning Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Middle East and Africa Fukangning Tablets Sales Market Share by Country (2021–2032)
 Figure 48. Middle East and Africa Fukangning Tablets Revenue Market Share by Country (2021–2032)
 Figure 49. Turkey Fukangning Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Saudi Arabia Fukangning Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. UAE Fukangning Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Global Sales Market Share of Fukangning Tablets by Type (2021–2032)
 Figure 53. Global Revenue Market Share of Fukangning Tablets by Type (2021–2032)
 Figure 54. Global Fukangning Tablets Price (US$/Unit) by Type (2021–2032)
 Figure 55. Global Sales Market Share of Fukangning Tablets by Application (2021–2032)
 Figure 56. Global Revenue Market Share of Fukangning Tablets by Application (2021–2032)
 Figure 57. Global Fukangning Tablets Price (US$/Unit) by Application (2021–2032)
 Figure 58. Fukangning Tablets Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure